Sanofi (SNY)

Sanofi records an AlphaScore of 67/100 within the Healthcare sector, backed by a market capitalization of $96.01 billion and a price of $40.07. Important fundamentals feature a gross margin of 72.07% and a modest debt-to-equity ratio of 0.34, reflecting reasonable balance sheet leverage. A notable strength is its high dividend subScore of 100 paired with a dividend yield of 6.01%, appealing to income-focused frameworks. Conversely, a primary risk is its lower return on equity of 5.71%, indicating weaker relative profitability on shareholder capital. Evidence is limited to this snapshot date of 2026-10-11.

Written 11/10/2026, 00:23:07 UTC · Snapshot 11/10/2026